Research summary, editorial or commentary, 2022

Aegrescit medendo: orthopedic disability in electrophysiology, call for fluoroscopy elimination, review and commentary

Rubenstein DS, Holmes BB, Manfredi JA, McKillop MS, Netzler PC, Ward CC. Journal of Interventional Cardiac Electrophysiology. 2022

Read the original paper

In plain language

This commentary argues that lead aprons are linked to high rates of spine and joint disorders among electrophysiologists and lab staff, and outlines how electroanatomic mapping and intracardiac echo could remove fluoroscopy, and the need for aprons, from ablation and device implants.

At a glance

Type of study
Editorial or commentary
Who was studied
Electrophysiologists, Nurses, Radiologic technologists, Mixed lab staff, Interventional cardiologists
Summary based on
the full text

What it found

  • Cited data show degenerative spine disease among interventional cardiologists rose sharply between 1997 and 2015.

    Key figures: 8 in 1997 to 35% in 2015

  • A cited Canadian survey of interventional electrophysiologists reported high orthopedic injury and spondylosis prevalence, rising with years of practice.

    Key figures: 49% orthopedic injury; lumbar spondylosis 25.9%; cervical spondylosis 20.7%

  • Authors contrast an estimated 1 in 92 added lethal cancer risk from ablation workloads with at least 1 in 3 electrophysiology (EP) physicians suffering musculoskeletal disorders attributed to lead aprons.

    Key figures: 1 in 92 vs 1 in 3

  • Cited literature shows zero-fluoroscopy ablation is feasible: 93% of supraventricular tachycardia (SVT) patients had no fluoroscopy, and a multicenter trial found no differences in procedure time, complications or success.

    Key figures: 93% of 1,989 SVT patients; 1020 vs 2040 patients

  • Nurses and EP technicians wear aprons longer than physicians, yet no study has measured apron-time or its link to musculoskeletal disease; authors propose an apron-time metric.

    Key figures: 20-30 min longer

Limits to keep in mind

Narrative review and commentary with no systematic search or original data; musculoskeletal and cancer risk figures are drawn from cited surveys and estimates, and the 1-in-3 claim and extrapolation to staff are not directly measured.

How this summary was made

ORSIF prepared this summary with AI assistance from the full text of the paper. A program then checked that the passage supporting each finding appears word for word in that source. A person has not yet reviewed each summary, so read the original before relying on a number. ORSIF summarizes research and does not endorse any product or company. Report a problem with this summary.

Prepared November 3, 2026.